CMTA-STAR Research for Axonal Forms of CMT

…of upcoming clinical trials. CMTA-STAR OVERVIEW AND RESEARCH UPDATE This is an in-depth STAR research update led by CMTA Board Chair Gilles Bouchard and accompanied by CMT scientists and researchers…

CMTA Appoints Katherine Forsey Chief Research Officer

…response to the explosive growth of the CMTA’s signature research program, the Strategy to Accelerate Research (STAR). CMTA-STAR is funding more research projects than ever before and expanding its network…

$1 Million Gift Pledged to CMT Type 2 Research!

…conference, the CMTA has done exactly that with its Strategy to Accelerate Research (STAR), bringing top researchers together with pharmaceutical and biotechnology partners to accelerate scientific breakthroughs and develop therapies….

CMTA’s 40 Under 40

…she’s focused on rare neuromuscular diseases, conducting research in Germany and Portugal. Her expertise spans conditions like CMT and hereditary amyloidosis. Dr. Dohrn’s contributions encompass clinical research, genetics, neurophysiology and…

CMTA-STAR Research for Demyelinating Forms of CMT

…in-depth conversation about STAR please reach out to Jeana Sweeney, Chief Engagement and Gifts Officer: jeana@cmtausa.org. Support CMT Research READ MORE ABOUT CMTA-STAR RESEARCH FOR DEMYELINATING TYPES OF CMT CMT…

Our Research

…and research service industries, non-profit research organizations and the National Institutes of Health. These relationships are a critical part of the CMTA-STAR initiative’s goal of rapidly delivering therapies to CMT…

CMT1X Research

…you the research projects the CMTA is currently funding for 1X as well as a description of the remarkable STAR Biotech Alliance Partners with whom we collaborate to advance research